ReviewCancers2021

Efficacy and Safety of Neoadjuvant Gemcitabine Plus Nab-Paclitaxel in Borderline Resectable and Locally Advanced Pancreatic Cancer-A Systematic Review and Meta-Analysis.

Marko Damm et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.